Guest Speaker Dr. Chris Henshall works as an independent consultant, advising governments, public and private sector organisations on health, research and innovation policy. Chris has worked previously for the Health Promotion Research Trust, the UK Medical Research Council and the Department of Health and NHS in England. As Deputy Director of R&D for the Department and NHS, he…
Speaker Dr. Irfan Dhalla Vice-President of Evidence Development and Standards at Health Quality Ontario Health technology assessment and quality improvement have different historical and philosophical underpinnings, but people who use either approach share a common goal: better health care, and ultimately better health. The two approaches can be used together to achieve more than…
Event Details:
Date: Tuesday, November 21, 2017 (dinner, November 20, 2017) Venue: Lister Conference Centre, 1-047 Lister Centre, University of AlbertaLocation: Edmonton, Alberta
REGISTER HERE Subscribe to NOAHE updates
This year, APCC completes the circle with an innovative and action-driven agenda that strives for progress, not perfection. It is pushing the boundaries of primary care and concentrating on the patient's journey across the system. The IHE is pleased to be a sponsor for APCC 2017: Advancing Patient Collaborative Care where participants will be inspired to build new momentum and…
21 October 2018 Toronto, Ontario On October 21, 2018, in conjunction with the 2018 Annual CAPT Conference, the Institute of Health Economics (IHE) and the Canadian Association for Population Therapeutics (CAPT) co-hosted the IHE/CAPT Real World Evidence Workshop. The intent of the workshop was to identify key opportunities for RWE to support decision-making throughout the pharmaceutical…
3 June 2018 Vancouver, British Columbia On June 3rd, as part of the 2018 Health Technology Assessment International (HTAi) Annual Conference in Vancouver, the Institute of Health Economics (IHE) led a panel presentation on facilitators, innovators, and innovations in chronic obstructive pulmonary disease (COPD) care in Canada. The panel Facilitating Adoption of Innovative Practices…
Real World Evidence (RWE) studies investigate the impact of an intervention or technology on health outcomes and resource utilization in clinical conditions outside of the controlled clinical trial setting. The evidence is generated from routinely collected health data to evaluate the safety, effectiveness, and value of newly introduced or existing health technologies and/or other…
Showcasing Alberta Applied Research The ‘Fit for Work’ Project: Living and working well with arthritis A project supported by AbbVie and Alberta Economic Development and Trade in partnership with the Alberta Schools Employee Benefit Plan. Providing lessons for employees and employers around tools and resources to make workplaces healthy and productive. Speakers Dr. Diane Lacaille,…
In recent years, the interest and need for real-world evidence (RWE) has been increasing due to the advent of innovative, yet expensive, pharmaceutical drugs, e.g. in the context of the evidence gaps for rare diseases. Numerous initiatives are undergoing worldwide to assess the potential use of RWE in decision making on drug regulation and health technology assessment (HTA). However,…
The purpose of this event is to provide a platform for shared learning and to showcase CADTH and Alberta initiatives on the creation and uptake of evidence-based guidance/direction from HTA and related processes. It will provide an opportunity for reflection from clinical leaders/practitioners on where processes are working well and on how they might be adapted to be more meaningful…